Skip to main navigation Skip to search Skip to main content

Corrigendum to “Results of a clinical trial of ANG003, a non-porcine pancreatic enzyme replacement therapy, in people with cystic fibrosis”(Journal of Cystic Fibrosis, (2025), 24, 6, (1043-1050), (S1569199325015292), 10.1016/j.jcf.2025.07.008)

  • Meghana Sathe
  • , Steven D. Freedman
  • , Melissa S. Putman
  • , Robert Gallotto
  • , Marcie Clarkin
  • , Danielle Gallotto
  • , Kateryna Pierzynowska
  • , Drucy Borowitz
  • UTSW/Children's Health
  • Beth Israel Deaconess Medical Center
  • Massachusetts General Hospital
  • Anagram Therapeutics, Inc.
  • Lund University
  • The Kielanowski Institute of Animal Physiology and Nutrition of the Polish Academy of Sciences
  • Anara AB

Research output: Contribution to journalComment/debate

Abstract

The authors regret <the affiliation f of Kateryna Pierzynowska should be: fDepartment of Animal Physiology, The Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences, Jabłonna, Poland The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Pages (from-to)185
Number of pages1
JournalJournal of Cystic Fibrosis
Volume25
Issue number1
DOIs
StatePublished - Jan 2026

Fingerprint

Dive into the research topics of 'Corrigendum to “Results of a clinical trial of ANG003, a non-porcine pancreatic enzyme replacement therapy, in people with cystic fibrosis”(Journal of Cystic Fibrosis, (2025), 24, 6, (1043-1050), (S1569199325015292), 10.1016/j.jcf.2025.07.008)'. Together they form a unique fingerprint.

Cite this